Unigene Laboratories, Inc.
| OTC Markets: UGNEQ
Unigene Laboratories, Inc. is a biopharmaceutical company, which engages in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company operates through one segment, which is focused on the research, production and delivery of small proteins, referred to as peptides, for medical use. It offers peptide drug delivery and manufacturing technologies under brand name Peptelligence. The company operates through two business units: Unigene Biotechnologies & Unigene Therapeutics. The Unigene Therapeutics business unit includes pipeline of proprietary peptide development programs which focuses on metabolic disease and inflammation. The Unigene Biotechnologies business unit focuses on expanding its peptelligence platform of peptide oral drug delivery and manufacturing assets. Unigene Laboratories was founded by Jay Levy, Ronald S. Levy and Warren P. Levy in October 31, 1980 and is headquartered in Boonton, NJ.